Morristown, N.J., January 5, 2016 – Capsugel today announced that it has completed its acquisitions of Xcelience and Powdersize. Xcelience and Powdersize are now part of Capsugel's Dosage Form Solutions business unit, which partners with pharmaceutical and health and nutrition customers around the world to advance products through an integrated approach to the design, development and manufacture of high-quality, innovative dosage forms.

The acquisitions, announced on December 14, 2015, provide Capsugel with specialized clinical trial manufacturing and supply capabilities for a broad range of solid dosage forms; development and manufacturing for specialized products such as highly potent and controlled substance compounds; and micronization capabilities that augment the company's existing formulation design services and premier bioavailability enhancement technology platform. When combined with Capsugel’s wide array of industry-leading hard capsule technologies, the expanded capabilities of Capsugel Dosage Form Solutions make the company better positioned than ever to partner with customers to deliver innovative, patient-centric dosage forms and solutions.

ABOUT CAPSUGEL
Capsugel is a global leader in delivering high-quality, innovative dosage forms and solutions to its customers in the health care industry.  The company’s Hard Capsule business offers customers the broadest portfolio of gelatin, vegetarian, and other specialized capsule technologies.  Capsugel’s Dosage Form Solutions (DFS) business utilizes an array of proprietary technologies and specialized manufacturing capabilities to solve customers’ most pressing product development challenges, including bioavailability enhancement, modified release, abuse deterrence, biotherapeutic processing, and inhalation formulation.  The company's fast-to-clinic program streamlines product development from pre-formulation through clinical and commercial supply for finished dosage forms.  Headquartered in Morristown, N.J., Capsugel serves more than 4,000 customers in more than 100 countries.  For additional information, visit www.capsugel.com.

For media inquiries, please contact: